California Institute for Regenerative Medicine (Cirm)

Plus: Fresenius and NS Pharma name new presidents, and updates from The Francis Crick Institute, CIRM, Nuvalent and more

Plus: Nassim Usman at the helm at Totus as it raises $66M series B round, and updates from Tourmaline, HKEX, CIRM, CorMedix and RiverVest

Plus: Filosi named CEO at Diaccurate, and updates from CIRM and City of Hope

Perspectives from innovators and policy professionals on what it takes to get next-generation technologies to diverse populations

Plus: Exelixis proposes new directors amid ongoing tussle with activist investor and updates from Jasper, CIRM, Visus, Curemark and more

Plus: Mahmood leaving Nkarta for CEO role and updates from CIRM, CFF 

Bay Area biotech is finding secreted proteins for age-related diseases systematically

Plus FDA approves Servier’s Tibsovo and updates from Avadel, HHS and more

Plus: Korsuva approved, Kymriah setback, tebentafusp under review and updates from UC, AbbVie, DiCE, AllStripes, Xalud and more

Susan Tousi was promoted to chief commercial officer at Illumina Inc. (NASDAQ:ILMN). Tousi joined the genome sequencing company in 2012 as VP of engineering, and was most recently SVP and chief